The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, X.
Right arrow Articles by Siliciano, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, X.
Right arrow Articles by Siliciano, R. F.
The Journal of Immunology, 2002, 169: 4222-4229.
Copyright © 2002 by The American Association of Immunologists

Direct Priming and Cross-Priming Contribute Differentially to the Induction of CD8+ CTL Following Exposure to Vaccinia Virus Via Different Routes1

Xuefei Shen*, S. B. Justin Wong{dagger}, Christopher B. Buck{dagger}, Jiangwen Zhang{dagger} and Robert F. Siliciano2,*,{dagger},{ddagger}

Programs in * Biochemistry, Cellular and Molecular Biology, and {dagger} Cellular and Molecular Medicine, and {ddagger} Graduate Program in Immunology and Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205

To explore the relative importance of direct presentation vs cross-priming in the induction of CTL responses to viruses and viral vectors, we generated a recombinant vaccinia vector, vUS11, expressing the human CMV (HCMV) protein US11. US11 dislocates most allelic forms of human and murine MHC class I heavy chains from the lumen of the endoplasmic reticulum into the cytosol, where they are degraded by proteasomes. Expression of US11 dramatically decreased the presentation of viral Ag and CTL recognition of infected cells in vitro without significantly reducing total cell surface MHC class I levels. However, because US11 is an endoplasmic reticulum resident membrane protein, it cannot block presentation by non-infected cells that take up Ag through the cross-priming pathway. We show that the expression of US11 strongly inhibits the induction of primary CD8+ CTLs when the infection occurs via the i.p. or i.v. route, demonstrating that direct priming is critical for the induction of CTL responses to viral infections introduced via these routes. This effect is less dramatic following i.m. infection and is minimal after s.c. or intradermal infection. Thus, classic MHC class I Ag presentation and cross-priming contribute differentially to the induction of CD8+ CTLs following exposure to vaccinia virus via different routes.




This article has been cited by other articles:


Home page
J. Immunol.Home page
I. A. Cockburn, S. Chakravarty, M. G. Overstreet, A. Garcia-Sastre, and F. Zavala
Memory CD8+ T Cell Responses Expand When Antigen Presentation Overcomes T Cell Self-Regulation
J. Immunol., January 1, 2008; 180(1): 64 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Gasteiger, W. Kastenmuller, R. Ljapoci, G. Sutter, and I. Drexler
Cross-Priming of Cytotoxic T Cells Dictates Antigen Requisites for Modified Vaccinia Virus Ankara Vector Vaccines
J. Virol., November 1, 2007; 81(21): 11925 - 11936.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Bins, M. C. Wolkers, M. D. van den Boom, J. B. A. G. Haanen, and T. N. M. Schumacher
In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity
J. Immunol., August 15, 2007; 179(4): 2126 - 2133.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Saito, T. Yajima, S. Kumabe, T. Doi, H. Yamada, S. Sad, H. Shen, and Y. Yoshikai
Impaired Protection against Mycobacterium bovis Bacillus Calmette-Guerin Infection in IL-15-Deficient Mice
J. Immunol., February 15, 2006; 176(4): 2496 - 2504.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. N. Steele, Z. R. Balsara, and M. N. Starnbach
Hematopoietic Cells Are Required to Initiate a Chlamydia trachomatis-Specific CD8+ T Cell Response
J. Immunol., November 15, 2004; 173(10): 6327 - 6337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. B. J. Wong, C. B. Buck, X. Shen, and R. F. Siliciano
An Evaluation of Enforced Rapid Proteasomal Degradation as a Means of Enhancing Vaccine-Induced CTL Responses
J. Immunol., September 1, 2004; 173(5): 3073 - 3083.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. M. Thomas, L. M. Santarsiero, E. R. Lutz, T. D. Armstrong, Y.-C. Chen, L.-Q. Huang, D. A. Laheru, M. Goggins, R. H. Hruban, and E. M. Jaffee
Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
J. Exp. Med., August 2, 2004; 200(3): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Mercier, S. Verhaagh, J. Goudsmit, A. Lemckert, M. Monteil, M. Havenga, and M. Eloit
Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo
J. Gen. Virol., May 1, 2004; 85(5): 1227 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Maranon, J.-F. Desoutter, G. Hoeffel, W. Cohen, D. Hanau, and A. Hosmalin
Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes
PNAS, April 20, 2004; 101(16): 6092 - 6097.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Daftarian, S. Ali, R. Sharan, S. F. Lacey, C. La Rosa, J. Longmate, C. Buck, R. F. Siliciano, and D. J. Diamond
Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge
J. Immunol., October 15, 2003; 171(8): 4028 - 4039.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Webby, S. Andreansky, J. Stambas, J. E. Rehg, R. G. Webster, P. C. Doherty, and S. J. Turner
Protection and compensation in the influenza virus-specific CD8+ T cell response
PNAS, June 10, 2003; 100(12): 7235 - 7240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.